Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Exhaled matrix metalloproteinase-9 in lung cancer.

Carpagnano GE, Palladino GP, Martinelli D, Lacedonia D, Orlando S, Foschino-Barbaro MP.

Rejuvenation Res. 2012 Aug;15(4):359-65. doi: 10.1089/rej.2011.1254.

PMID:
22877564
2.

Increased levels of exhaled sICAM1, sVCAM1, and sE-selectin in patients with non-small cell lung cancer.

Zhou F, Chen J, Tao G, Zhu M, Xie W, Cao X.

Respir Med. 2014 Nov;108(11):1670-6. doi: 10.1016/j.rmed.2014.08.003. Epub 2014 Aug 20.

3.

3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer.

Carpagnano GE, Foschino-Barbaro MP, Mulé G, Resta O, Tommasi S, Mangia A, Carpagnano F, Stea G, Susca A, Di Gioia G, De Lena M, Paradiso A.

Am J Respir Crit Care Med. 2005 Sep 15;172(6):738-44. Epub 2005 Jun 9.

PMID:
15947287
4.

CEA, SCC and NSE levels in exhaled breath condensate--possible markers for early detection of lung cancer.

Zou Y, Wang L, Zhao C, Hu Y, Xu S, Ying K, Wang P, Chen X.

J Breath Res. 2013 Dec;7(4):047101. doi: 10.1088/1752-7155/7/4/047101. Epub 2013 Nov 1.

PMID:
24185583
5.

Enhanced exhalation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with COPD exacerbation: a prospective study.

Kwiatkowska S, Noweta K, Zieba M, Nowak D, Bialasiewicz P.

Respiration. 2012;84(3):231-41. doi: 10.1159/000339417. Epub 2012 Jul 24.

PMID:
22832426
6.

Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: how hot is the link?

Carpagnano GE, Spanevello A, Palladino GP, Gramiccioni C, Ruggieri C, Carpagnano F, Foschino Barbaro MP.

Lung Cancer. 2010 Jan;67(1):108-13. doi: 10.1016/j.lungcan.2009.03.033.

PMID:
19423183
7.

Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8.

Carpagnano GE, Palladino GP, Lacedonia D, Koutelou A, Orlando S, Foschino-Barbaro MP.

BMC Cancer. 2011 Jun 7;11:226. doi: 10.1186/1471-2407-11-226.

8.

Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer.

Xiao P, Chen JR, Zhou F, Lu CX, Yang Q, Tao GH, Tao YJ, Chen JL.

Lung Cancer. 2014 Jan;83(1):56-60. doi: 10.1016/j.lungcan.2013.09.008. Epub 2013 Sep 25.

PMID:
24268095
9.

3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.

Carpagnano GE, Foschino-Barbaro MP, Spanevello A, Resta O, Carpagnano F, Mulé G, Pinto R, Tommasi S, Paradiso A.

Am J Respir Crit Care Med. 2008 Feb 1;177(3):337-41. Epub 2007 Oct 25.

PMID:
17962633
10.

Inflammatory cytokines and VEGF measured in exhaled breath condensate are correlated with tumor mass in non-small cell lung cancer.

Brussino L, Culla B, Bucca C, Giobbe R, Boita M, Isaia G, Heffler E, Oliaro A, Filosso P, Rolla G.

J Breath Res. 2014 Jun;8(2):027110. doi: 10.1088/1752-7155/8/2/027110. Epub 2014 May 27.

PMID:
24861949
11.

Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients.

Carpagnano GE, Spanevello A, Carpagnano F, Palladino GP, Prato R, Martinelli D, Digioia G, Foschino-Barbaro MP.

Lung Cancer. 2009 Jun;64(3):334-40. doi: 10.1016/j.lungcan.2008.09.004. Epub 2008 Nov 7.

PMID:
18995925
12.

Exhaled breath analysis in suspected cases of non-small-cell lung cancer: a cross-sectional study.

Corradi M, Poli D, Banda I, Bonini S, Mozzoni P, Pinelli S, Alinovi R, Andreoli R, Ampollini L, Casalini A, Carbognani P, Goldoni M, Mutti A.

J Breath Res. 2015 Jan 29;9(2):027101. doi: 10.1088/1752-7155/9/2/027101.

PMID:
25634546
13.

Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients.

Carpagnano GE, Palladino GP, Gramiccioni C, Foschino Barbaro MP, Martinelli D.

Lung Cancer. 2010 May;68(2):305-7. doi: 10.1016/j.lungcan.2010.01.020. Epub 2010 Feb 25.

PMID:
20188432
14.

IL-2, TNF-alpha, and leptin: local versus systemic concentrations in NSCLC patients.

Carpagnano GE, Spanevello A, Curci C, Salerno F, Palladino GP, Resta O, Di Gioia G, Carpagnano F, Foschino Barbaro MP.

Oncol Res. 2007;16(8):375-81.

PMID:
17913045
15.

Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer.

Carpagnano GE, Foschino-Barbaro MP, Resta O, Gramiccioni E, Carpagnano F.

Oncology. 2004;66(3):180-4.

PMID:
15218307
16.

Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.

Li L, Mei TH, Zhou XD, Zhang XG.

Ai Zheng. 2009 Jan;28(1):60-3. Epub 2009 Jan 16.

PMID:
19448419
17.

VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.

Dalaveris E, Kerenidi T, Katsabeki-Katsafli A, Kiropoulos T, Tanou K, Gourgoulianis KI, Kostikas K.

Lung Cancer. 2009 May;64(2):219-25. doi: 10.1016/j.lungcan.2008.08.015. Epub 2008 Oct 9.

PMID:
18845357
18.

Matrix metalloproteinase-9 in broncho-alveolar lavage fluid of patients with non-small cell lung cancer.

Bugdayci G, Kaplan T, Sezer S, Turhan T, Koca Y, Kocer B, Yildirim E.

Exp Oncol. 2006 Jun;28(2):169-71.

PMID:
16837913
19.

Exhaled HPV infection in lung cancer: role of MA at 3p.

Carpagnano GE, Lacedonia D, Crisetti E, Palladino GP, Saliani V, Zoppo LD, Antonetti R, Natalicchio I, Foschino-Barbaro MP.

Arch Med Res. 2014 Jul;45(5):383-7. doi: 10.1016/j.arcmed.2014.06.006. Epub 2014 Jun 21.

PMID:
24962429
20.

Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer.

Carpagnano GE, Resta O, Foschino-Barbaro MP, Gramiccioni E, Carpagnano F.

Int J Biol Markers. 2002 Apr-Jun;17(2):141-5.

PMID:
12113582

Supplemental Content

Support Center